Pharmaceutical

COSCIENS Biopharma Announces Appointment of Pierre Labbé as Director

TORONTO, ONTARIO, Oct. 01, 2024 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a…

1 year ago

Pliant Therapeutics Appoints Gary Palmer, M.D. as Senior Vice President of Medical Affairs

Former Bristol Myers Squibb Global Medical Affairs Lead brings over 25 years of experience to Pliant SOUTH SAN FRANCISCO, Calif.,…

1 year ago

BioAge Labs Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares and Closing of the Concurrent Private Placement

RICHMOND, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (“BioAge”) (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic…

1 year ago

Gyre Therapeutics to Present at 8th Annual H.C. Wainwright MASH Investor Conference

SAN DIEGO, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with clinical…

1 year ago

Curve Therapeutics further strengthens leadership team with the appointment of Andre Hoekema as new Chair of Board

Dr Hoekema brings over four decades of successful biotech and life science leadershipDr Cora Griffin appointed to head up business…

1 year ago

TAPROOT BOARD OF DIRECTORS WELCOMES LESLIE HARDY, GLOBAL DEIB STRATEGY, SOCIAL RESPONSIBILITY, AND WELLBEING LEADER

NEW YORK, Oct. 1, 2024 /PRNewswire/ -- Taproot is pleased to announce the election of Leslie Hardy, Director of Inclusion and…

1 year ago

Transmission Electron Microscope Market to Grow by USD 528.8 Million (2024-2028), Driven by Nanotechnology Focus, AI-Powered Market Evolution Report – Technavio

NEW YORK, Oct. 1, 2024 /PRNewswire/ -- Report on how AI is driving market transformation- The global transmission electron microscope market…

1 year ago

Rapid Dose Announces Payment in Shares for Interest on Secured Debt

Burlington, Ontario--(Newsfile Corp. - October 1, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today…

1 year ago